Brief Summary

Prescription — Acquisitive Prescription — Delay in completion of acquisitive prescription — Plaintiff sought to declare ownership of property through acquisitive prescription, claiming continuous possession since June 1986 — Defendants, as executrixes of the deceased owner’s estate, raised a special plea arguing that the death of the owner constituted "superior force" preventing the interruption of prescription — Court held that the death of the owner did indeed constitute "superior force" under section 3(1)(a) of the Prescription Act, delaying the completion of the prescription period until after the appointment of the executrixes, thus upholding the special plea.

Comprehensive Summary

Summary of Judgment

1. Introduction

The proceedings were an action in the Gauteng Division, Johannesburg, in which the plaintiff sought declaratory relief that she had become the owner of immovable property by acquisitive prescription under the Prescription Act 68 of 1969. The dispute arose after the death of the registered owner of the property, and the litigation focused on whether the statutory thirty-year prescription period had been completed.

The plaintiff was Hassody Khatha. The first and second defendants, Primathie Pillay N.O. and Kanderuby Ramoothy N.O., were sued in their capacities as the executrixes of the estate of the registered owner, Lutchmia Katha. The third defendant was the Master of the High Court, Johannesburg, cited in relation to the administration of the deceased estate.

Procedurally, the defendants delivered a special plea aimed at defeating the plaintiff’s acquisitive prescription claim on the basis that the prescription period had not been completed when the claim was instituted or pleaded. The parties agreed in pre-trial minutes that the special plea would be determined separately and on the basis of common-cause facts, without oral evidence. At the commencement of the hearing, the court made a formal separation order under Uniform Rule 33(4), staying the remaining issues pending determination of the special plea.

The general subject-matter of the dispute was the interpretation and application of section 3(1)(a) of the Prescription Act (dealing with circumstances postponing completion of acquisitive prescription), specifically whether the death of the person against whom prescription is running constitutes “superior force” preventing interruption, and thereby delaying completion of prescription.

2. Material Facts

The matter concerned immovable property in Benoni which, at all relevant times, was registered in the name of Lutchmia Katha, the plaintiff’s mother-in-law. Lutchmia Katha died on 18 August 2014.

It was common cause that the first and second defendants were appointed as executrixes of the deceased estate by letters of executorship issued on 2 October 2017. Until that appointment, there was no executor in office.

The plaintiff pleaded that she had possessed the property continuously and openly, and as if she were the owner, from June 1986 for a period exceeding thirty years. On that pleaded footing, the plaintiff’s case implied completion of the thirty-year period by 31 May 2016 (calculated from 1 June 1986 as the earliest possible start date contemplated on the agreed facts).

The defendants’ special plea proceeded on the assumption (for purposes of the separated issue) that the plaintiff could establish the other elements of acquisitive prescription commencing from 1 June 1986. The special plea contended, however, that prescription could not have been completed by 31 May 2016 because Lutchmia Katha’s death on 18 August 2014 constituted “superior force” under section 3(1)(a), preventing interruption of prescription as contemplated in section 4 until an executor was appointed. On that premise, the defendants contended that completion of prescription was postponed until three years after the impediment ceased, which they said occurred on 2 October 2017, yielding a completion date of 1 October 2020.

The court recorded that it was not asked to decide whether acquisitive prescription had in fact been interrupted (judicially or otherwise) before completion. The separated determination concerned only whether death delayed completion of the prescription period.

3. Legal Issues

The central legal question was whether the death of the registered owner (the person against whom acquisitive prescription was running) constitutes “superior force” for purposes of section 3(1)(a) of the Prescription Act 68 of 1969, in circumstances where no executor had yet been appointed and the estate could not institute process to interrupt prescription under section 4.

Closely connected to that question was the further question of timing: if death constituted superior force, when the impediment ceased (in particular, whether it ceased upon appointment of the executrixes), and consequently whether the plaintiff’s pleaded completion date was legally sustainable.

The dispute was primarily one of law, involving statutory interpretation (text, context, and purpose), and its application to a largely common-cause factual matrix. It also implicated the relationship between the Act and the common-law maxim contra non valentem agere nulla currit praescriptio, insofar as the court considered an alternative analysis should section 3(1)(a) be found not to cover death.

4. Court’s Reasoning

The court approached the interpretation of “superior force” in section 3(1)(a) by applying orthodox interpretive principles requiring a simultaneous consideration of text, context, and purpose, as recently summarised in Constitutional Court jurisprudence. It emphasised that the phrase “superior force” is not defined in the Act and had not been judicially considered in relation to section 3(1)(a) itself, thereby requiring principled interpretation rather than reliance on direct precedent.

On the text, the court accepted the defendants’ submission that, at least until appointment of an executor, a deceased estate cannot perform juristic acts such as instituting proceedings, and that this reality fits the ordinary meaning of being “prevented” from interrupting prescription. The court noted authority suggesting that an estate without an executor cannot sue to interrupt prescription, and treated this practical inability as strongly supporting the conclusion that death (pending executorship) can fall within “superior force” in section 3(1)(a).

On context, the plaintiff advanced two principal interpretive arguments. First, the plaintiff argued that “superior force” should be interpreted eiusdem generis with the other impediments listed in section 3(1)(a) (minority, insanity, curatorship), and suggested that death should not qualify because heirs can initiate steps to procure appointment of an executor. The court rejected this argument as a matter of principle, reasoning that prescription runs against the estate, not the heirs, and that the salient enquiry is not whether third parties can sometimes act to end the impediment, but whether the owner is in a position to protect its rights. The court considered scenarios where death occurs shortly before the notional completion date, making it practically impossible for anyone to procure an executor’s appointment before completion, thereby demonstrating why death can function as an impediment beyond the control of the person against whom prescription is running.

The court further held that an eiusdem generis approach did not assist the plaintiff because death pending executorship is analogous to the other listed impediments in the sense that the person (or estate) is not in a position to act to protect rights. The court drew support from Supreme Court of Appeal authority interpreting “superior force” in section 13(1)(a) (extinctive prescription) as covering an analogous situation where a company in liquidation lacked an appointed liquidator, even though interested parties could seek such appointment.

Second, the plaintiff argued by comparison to section 13 of the Prescription Act that the Legislature expressly addressed death in section 13(1)(h) (for extinctive prescription), and therefore “superior force” in section 13(1)(a) should not include death; by parity of language, section 3(1)(a) should similarly exclude death. The court did not accept that this comparison was decisive. It reasoned that overlapping provisions can coexist without depriving either of practical effect, and noted appellate authority describing section 13 as unclear and interpretively problematic. The court also stressed that interpretive presumptions about consistent meaning are not immutable and can yield where they would produce absurdity or frustrate legislative intention. In the court’s view it would be absurd to conclude that a deceased person with no executor is not prevented by superior force from interrupting prescription.

The court then considered the common law and the presumption against altering it absent clear legislative intention. It referred to the common-law principle that prescription is suspended where the person against whom it runs is unable to assert rights, encapsulated in contra non valentem agere nulla currit praescriptio. The judgment reviewed authority indicating that acquisitive prescription does not operate where the owner lacks a legal right or ability to prevent the adverse possession, and it observed that earlier decisions had treated death pending appointment of an executor as a paradigm case for suspension, unless there existed a “statutory executor” who could act immediately after death.

In dealing with Minnaar v Rautenbach, the court explained that Minnaar (a common-law decision under earlier legal materials) suggested heirs could avoid suspension by requesting appointment of an executor. The present court declined to follow Minnaar, reasoning that it overlooked a crucial distinguishing feature in Barker v Chadwick (the presence there of a statutory executor), and further that negligence or “idleness” of heirs is not a substantive requirement for acquisitive prescription. The court treated Minnaar as non-binding and inconsistent with a correct understanding of the relevant principles.

Turning to purpose, the court adopted the view that the phrase “prevented by superior force” was intended to rationalise and broadly capture circumstances where a person is objectively disabled from protecting rights by interrupting prescription. It emphasised that the principal rationales for acquisitive prescription in South African law (punishment of owner inattention and legal certainty) are grounded in societal interests rather than the personal deserts of the possessor. Against that background, the court considered it inappropriate to narrow the contra non valentem principle or the scope of section 3(1)(a) by importing an enquiry into the possessor’s labour or investment in the property.

The court also linked the interpretive choice to constitutional considerations, noting the protection against arbitrary deprivation of property and the principle of preferring interpretations that are less invasive of fundamental rights when reasonably possible. It stated that excluding death from the scope of “superior force” could facilitate arbitrary transfers of ownership from an estate to a possessor during a period when the estate cannot act.

On the combined assessment of text and purpose, and with contextual considerations not outweighing those factors, the court concluded that “superior force” in section 3(1)(a) includes the death of the owner where, prior to appointment of an executor, the estate cannot interrupt prescription by service of process. It held that the impediment ceased when the executrixes were appointed on 2 October 2017, and therefore the period of acquisitive prescription (assumed to have commenced in June 1986) would only be completed on 1 October 2020.

The court further reasoned, in the alternative, that even if section 3(1)(a) did not cover death and the Act were “silent”, the common law would suspend running of acquisitive prescription from the date of death until appointment of an executor. On that alternative analysis, the period would in any event not have been completed by the latest date signified by the plaintiff’s pleadings; on the court’s calculation, prescription would only have completed on 15 July 2019 at the earliest.

5. Outcome and Relief

The court upheld the defendants’ special plea and held that, whether under section 3(1)(a) (as interpreted) or under the common-law suspension principle, the plaintiff’s acquisitive prescription period had not been completed by the relevant pleaded dates. Consequently, the plaintiff’s principal claim seeking a declaration of ownership by acquisitive prescription could not succeed on the pleadings as framed.

The court ordered that the special plea be separated and determined first, that the remaining issues be stayed pending disposition of the special plea, and that the special plea be upheld. The court dismissed Claim A (the acquisitive prescription claim) and awarded costs to the defendants on the ordinary principle that costs follow the result.

Cases Cited

Shoprite Checkers (Pty) Ltd v Mafate 2023 (4) SA 537 (SCA).

Minister of Police and Others v Fidelity Security Services (Pty) Ltd [2022] ZACC 16 (CC).

Commissioner for Inland Revenue v Emary NO 1961 (2) SA 621 (A).

Yoonuce v Pillay 1964 (2) SA 286 (D).

Mostert NO v Old Mutual Life Assurance Company (South Africa) Limited 2001 (4) SA 159 (SCA).

Thorpe v Trittenwein 2007 (2) SA 172 (SCA).

Barker NO v Chadwick 1974 (1) SA 461 (D).

Botha v Williams 2012 JDR 0582 (GSJ).

Minnaar v Rautenbach [1999] 1 All SA 571 (NC).

Knysna Hotel CC v Coetzee NO [1997] ZASCA 114; 1998 (2) SA 743 (SCA).

ABP 4x4 Motor Dealers (Pty) Ltd v IGI Insurance Company Limited 1999 (3) SA 924 (SCA).

Panamo Properties (Pty) Ltd and Another v Nel and Others NNO 2015 (5) SA 63 (SCA).

Leipsig v Bankorp Ltd [1993] ZASCA 198; 1994 (2) SA 128 (A).

Public Carriers Association and Others v Toll Road Concessionaries (Pty) Ltd and Others 1990 (1) SA 925 (A).

Minister of the Interior v Machadodorp Investments (Pty) Ltd and Another 1957 (2) SA 395 (A).

MEC, Department of Agriculture, Conservation and Environment v HTF Developers (Pty) Ltd 2008 (2) SA 319 (CC); [2007] ZACC 25.

S v Dlamini; S v Dladla and Others; S v Joubert; S v Schietekat 1999 (4) SA 623 (CC); [1999] ZACC 8.

S v Litako and Others 2015 (3) SA 287 (SCA).

Casserley v Stubbs 1916 TPD 310.

Estate Dambuza v Estate Mcikwa 1946 AD 94.

Louw v Louw 1933 CPD 163.

Morkel’s Transport (Pty) Ltd v Melrose Foods (Pty) Ltd 1972 (2) SA 464 (W).

Pezula Private Estate (Pty) Ltd v Metelerkamp 2014 (5) SA 37 (SCA).

Magnificent Mile Trading 30 (Pty) Ltd v Celliers NO 2020 (4) SA 375 (CC).

Pienaar v Rabie 1983 (3) SA 126 (A).

Road Accident Fund v Mdeyide 2011 (2) SA 26 (CC); [2010] ZACC 18.

Welgemoed v Coetzer 1946 TPD 701.

First National Bank of South Africa Limited t/a Wesbank v Commissioner, South African Revenue Service; First National Bank of South Africa Limited t/a Wesbank v Minister of Finance 2002 (4) SA 768 (CC).

Pye (Oxford) Ltd v United Kingdom 2006 43 European Journal of Risk Regulation 3 (IV).

Tshwane City v Link Africa 2015 (6) SA 440 (CC).

Principal Immigration Officer v Bhula 1931 AD 323.

Road Accident Fund v Smith NO 1999 (1) SA 92 (SCA).

Lombo v African National Congress 2002 (5) SA 668 (SCA).

Marais v Commercial Union Insurance Company of South Africa Limited 1977 (2) SA 269 (T).

Erasmus v Protea Assuransiemaatskappy Bpk 1982 (2) SA 64 (N).

Oertel NNO v Director of Local Government 1981 (4) SA 491 (T).

Oertel NNO v Direkteur van Plaaslike Bestuur 1983 (1) SA 354 (A).

Legislation Cited

Prescription Act 68 of 1969, sections 1, 3(1)(a), 4, 8(2), 13(1)(a), 13(1)(h).

Administration of Estates Act 66 of 1965, sections 14(1), 18.

Constitution of the Republic of South Africa, 1996, sections 25(1), 39(2).

Rules of Court Cited

Uniform Rule 33(4).

Held

The court held that the death of the person against whom acquisitive prescription is running constitutes “superior force” within the meaning of section 3(1)(a) of the Prescription Act 68 of 1969, where death (pending appointment of an executor) prevents interruption of the running of prescription by service of process contemplated in section 4.

It held that the impediment ceased upon the appointment of the executrixes on 2 October 2017, with the result that the thirty-year prescription period relied upon by the plaintiff would only have been completed on 1 October 2020, and therefore had not been completed by the dates contemplated in the plaintiff’s pleadings.

The court further held that even if section 3(1)(a) did not apply and the Act were silent, the common law would suspend the running of acquisitive prescription upon death until appointment of an executor, which likewise meant the plaintiff could not show completion of the prescription period on the pleaded basis. The defendants’ special plea was upheld and the plaintiff’s acquisitive prescription claim was dismissed with costs.

LEGAL PRINCIPLES

The judgment applied the principle that statutory interpretation requires a unified evaluation of text, context, and purpose, and that interpretive presumptions (including consistent word usage) may be departed from where they would cause absurdity or frustrate the legislative scheme, provided the departure remains within what is reasonably possible on the language used.

It applied the principle that the phrase “prevented by superior force” in section 3(1)(a) is capable of extending to circumstances where the person against whom prescription runs is objectively unable to interrupt prescription by legal process, including where an estate lacks an appointed executor and thus cannot institute proceedings to protect ownership.

The judgment affirmed the relevance of the common-law maxim contra non valentem agere nulla currit praescriptio in prescription law, and treated the Act as a partial codification such that common-law rules may continue to operate where the Act is silent and not inconsistent with it. On this footing, death pending appointment of an executor was treated as a circumstance suspending prescription at common law, if not addressed by the statutory “superior force” provision.

The judgment also applied the principle that statutes should, where reasonably possible, be interpreted in a manner that avoids outcomes inconsistent with constitutional property protection, including interpretations that could facilitate arbitrary deprivation of property in circumstances where the owner (or estate) is disabled from acting to protect its rights.

Khatha v Pillay and Others (35735/2018) [2023] ZAGPJHC 926; 2024 (1) SA 159 (GJ) (20 August 2023)